The historical rank and industry rank for Assertio Holdings's Net Margin % or its related term are showing as below:
ASRT'
s Net Margin % Range Over the Past 10 Years
Min: -218.28 Med: -20.78 Max: 70.17
Current: -218.28
ASRT's Net Margin % is ranked worse than 89.42% of 1021
companies
in the Drug Manufacturers industry
Industry Median: 3.76
vs ASRT: -218.28
Assertio Holdings Net Margin % Historical Data
The historical data trend for Assertio Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Assertio Holdings's Net Margin %
For the Drug Manufacturers - Specialty & Generic subindustry, Assertio Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Assertio Holdings's Net Margin % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Assertio Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Assertio Holdings's Net Margin % falls into.
Assertio Holdings Net Margin % Calculation
Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.
Assertio Holdings's Net Margin for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Assertio Holdings (NAS:ASRT) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Assertio Holdings Net Margin % Related Terms
Thank you for viewing the detailed overview of Assertio Holdings's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Assertio Holdings (Assertio Holdings) Business Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults 18 years of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASRT has been successfully added to your 